author-photo

Xinghao Ai

Shanghai Jiao Tong University

24

Papers

299

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Sintilimab, stereotactic body radiotherapy and granulocyte–macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial

2021 Radiation Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Lactate anions participate in T cell cytokine production and function.

2021 Science China-life Sciences
Show All
- Source
- Cite
- Save
Citations (1)
Safety but Limited Efficacy of Ensartinib in ROS1-Positive NSCLC: A Single-Arm, Multicenter Phase 2 Study.

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Durable Response to the Combination of Atezolizumab With Platinum-Based Chemotherapy in an Untreated Non-Smoking Lung Adenocarcinoma Patient With BRAF V600E Mutation: A Case Report.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of Niraparib as Maintenance Treatment in Patients with Extensive-Stage Small Cell Lung Cancer after First-Line Chemotherapy: A Randomized, Double-Blind, Phase 3 Study

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Pyrotinib combined with thalidomide in advanced non-small-cell lung cancer patients harboring HER2 exon 20 insertions (PRIDE): protocol of an open-label, single-arm phase II trial.

2021 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (0)
[Combination of Radiation Therapy and Immunotherapy for Non-small Cell Lung Cancer: Peer Exchange on Frontier Academic Topics].

2020 Chinese journal of lung cancer
Show All
- Source
- Cite
- Save
Citations (0)
Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study.

2020 Journal of Hematology & Oncology
Show All
- Source
- Cite
- Save
Citations (15)
Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway

2018 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (15)
Next generation sequencing reveals a novel ALK G1128A mutation resistant to crizotinib in an ALK-Rearranged NSCLC patient

2018 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (14)